Pathstone Family Office’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pathstone Family Office’s Portfolio HZNP Stock Details HZNP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$272K	Buy
2017 Q2	–	Sell
2017 Q1	$0	Buy